Bitcoin (BTC) may have finally found its footing after a steep correction from late-2025 highs.…
Read More »
Norway-based startup Lace has already raised $40 million in fresh funding, pointing to growing investor appetite for next-generation chipmaking technologies…
Read More »
Shares of Super Micro Computer dove on Friday, wiping out more than a quarter of the company’s value in a…
Read More »
U.S. stocks traded mixed on Wednesday as investors navigated fresh geopolitical risks and digested the latest inflation data.
Read More »
Zymeworks soared 34% after its partnered drug Ziihera posted strong Phase 3 data, with Jazz Pharmaceuticals showing it improved outcomes…
Read More »
Pacira jumped into M&A chatter after investor DOMA Perpetual urged a full sale, arguing the biotech could fetch $66/share. Activist…
Read More »
Nektar Therapeutics rises after reports of Eli Lilly’s buyout interest and strong Phase IIb results for REZPEG. With FDA Fast…
Read More »
Hims & Hers (HIMS) took a steep dive after U.S. regulators signaled an aggressive move against compounded versions of blockbuster…
Read More »
Shares of UnitedHealth Group (UNH) took a dive on Tuesday, leading a broad selloff across the health insurance sector after…
Read More »
Nanox’s planned acquisition of VasoHealthcare IT signals a strategic push to speed U.S. adoption of its AI imaging tech by…
Read More »
Cannabis stocks rallied this Friday after reports that the Trump administration is considering easing federal…
Read More »
